What is JAGX's earnings growth forecast for 2026-2026?
(NASDAQ: JAGX) Jaguar Health's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Jaguar Health's earnings in 2026 is -$49,232,000.
In 2026, JAGX is forecast to generate -$77,321,304 in earnings, with the lowest earnings forecast at -$74,289,096 and the highest earnings forecast at -$79,595,461.
What is JAGX's revenue growth forecast for 2026-2026?
(NASDAQ: JAGX) Jaguar Health's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Jaguar Health's revenue in 2026 is $27,075,000.
In 2026, JAGX is forecast to generate $248,235,340 in revenue, with the lowest revenue forecast at $238,492,770 and the highest revenue forecast at $255,535,594.
What is JAGX's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: JAGX) forecast ROA is -237.83%, which is lower than the forecast US Biotechnology industry average of -20.54%.
What is JAGX's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: JAGX) Jaguar Health's current Earnings Per Share (EPS) is -$638.23. In 2026, JAGX's EPS is forecast to hit -$5.79 (min: -$5.57, max: -$5.96).
What is JAGX's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: JAGX) forecast ROE is -380.52%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.